Chordate Medical Holding AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 1.75 million compared to SEK 0.108517 million a year ago. Revenue was SEK 1.92 million compared to SEK 0.163954 million a year ago.

Net loss was SEK 29.19 million compared to SEK 27.94 million a year ago. Basic loss per share from continuing operations was SEK 0.13 compared to SEK 0.18 a year ago.